Prestige Consumer Healthcare Inc.
PBH- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001295947
No open-market purchases or sales by Prestige Consumer Healthcare Inc. insiders were filed in the last 90 days; 319 institutions reported holding it in 13F filings for Q2 2026, worth $2.54B in total; Maverick Capital is the only superinvestor holding it.
Superinvestors holding PBH, Q2 2026
1 superinvestor reports holding Prestige Consumer Healthcare Inc. on Form 13F, worth $2.41M in total. Weight is Prestige Consumer Healthcare Inc.'s share of each 13F portfolio; actions compare shares with Q1 2026.
| Superinvestor | % of portfolio | Shares | Value | vs. previous quarter |
|---|---|---|---|---|
| Maverick CapitalLee Ainslie | <0.1% | 50,975 | $2.41M | New |
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of PBH each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2026
1 superinvestor holding at quarter end
Q4 2023
0 superinvestors holding at quarter end
- Sold out
- Maverick Capital
Q3 2023
1 superinvestor holding at quarter end
- Reduced
- Maverick Capital (−5.3%)
Q2 2023
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+279.9%)
Q1 2023
1 superinvestor holding at quarter end
- Reduced
- Maverick Capital (−75.2%)
Q4 2022
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+51.1%)
Q3 2022
1 superinvestor holding at quarter end
- Reduced
- Maverick Capital (−10.0%)
Q2 2022
1 superinvestor holding at quarter end
- Reduced
- Maverick Capital (−6.9%)
Q1 2022
1 superinvestor holding at quarter end
Q4 2021
0 superinvestors holding at quarter end
- Sold out
- Maverick Capital
Q3 2021
1 superinvestor holding at quarter end